Treatment of COVID-19 in High-Risk Outpatients (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

January 28, 2022

View Complete Issue Table of Contents 2019

Download PDF: US English

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2022 Jan 28;64(1643):e1

Disclosures

Objective(s)

Select a term to see related articles COVID-19 molnupiravir nirmatrelvir Paxlovid remdesivir Ritonavir sotrovimab Veklury

Last Update: July 18, 2023

View the Treatment of COVID-19 in High-Risk Outpatients Chart

Download PDF: US English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.